385 related articles for article (PubMed ID: 15564453)
1. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
Netter RC; Amberg SM; Balliet JW; Biscone MJ; Vermeulen A; Earp LJ; White JM; Bates P
J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
[TBL] [Abstract][Full Text] [Related]
2. Expanded tropism and altered activation of a retroviral glycoprotein resistant to an entry inhibitor peptide.
Amberg SM; Netter RC; Simmons G; Bates P
J Virol; 2006 Jan; 80(1):353-9. PubMed ID: 16352560
[TBL] [Abstract][Full Text] [Related]
3. The avian retrovirus avian sarcoma/leukosis virus subtype A reaches the lipid mixing stage of fusion at neutral pH.
Earp LJ; Delos SE; Netter RC; Bates P; White JM
J Virol; 2003 Mar; 77(5):3058-66. PubMed ID: 12584331
[TBL] [Abstract][Full Text] [Related]
4. Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions.
Young JK; Li D; Abramowitz MC; Morrison TG
J Virol; 1999 Jul; 73(7):5945-56. PubMed ID: 10364347
[TBL] [Abstract][Full Text] [Related]
5. The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion.
Babel AR; Bruce J; Young JA
PLoS One; 2007 Jan; 2(1):e171. PubMed ID: 17245447
[TBL] [Abstract][Full Text] [Related]
6. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion.
Ghosh JK; Shai Y
J Mol Biol; 1999 Sep; 292(3):531-46. PubMed ID: 10497019
[TBL] [Abstract][Full Text] [Related]
7. Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.
Liu S; Xiao G; Chen Y; He Y; Niu J; Escalante CR; Xiong H; Farmar J; Debnath AK; Tien P; Jiang S
Lancet; 2004 Mar; 363(9413):938-47. PubMed ID: 15043961
[TBL] [Abstract][Full Text] [Related]
8. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection.
Yao Q; Compans RW
Virology; 1996 Sep; 223(1):103-12. PubMed ID: 8806544
[TBL] [Abstract][Full Text] [Related]
9. Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation.
Delos SE; Godby JA; White JM
J Virol; 2005 Mar; 79(6):3488-99. PubMed ID: 15731243
[TBL] [Abstract][Full Text] [Related]
10. Structure and function study of paramyxovirus fusion protein heptad repeat peptides.
Wang XJ; Bai YD; Zhang GZ; Zhao JX; Wang M; Gao GF
Arch Biochem Biophys; 2005 Apr; 436(2):316-22. PubMed ID: 15797244
[TBL] [Abstract][Full Text] [Related]
11. Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.
Wang E; Sun X; Qian Y; Zhao L; Tien P; Gao GF
Biochem Biophys Res Commun; 2003 Mar; 302(3):469-75. PubMed ID: 12615056
[TBL] [Abstract][Full Text] [Related]
12. A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle.
Markosyan RM; Bates P; Cohen FS; Melikyan GB
Biophys J; 2004 Nov; 87(5):3291-8. PubMed ID: 15339808
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of membrane fusion inhibitors against the feline immunodeficiency virus.
Oishi S; Kodera Y; Nishikawa H; Kamitani H; Watabe T; Ohno H; Tochikura T; Shimane K; Kodama E; Matsuoka M; Mizukoshi F; Tsujimoto H; Fujii N
Bioorg Med Chem; 2009 Jul; 17(14):4916-20. PubMed ID: 19541488
[TBL] [Abstract][Full Text] [Related]
14. Design and characterization of human respiratory syncytial virus entry inhibitors.
Ni L; Zhao L; Qian Y; Zhu J; Jin Z; Chen YW; Tien P; Gao GF
Antivir Ther; 2005; 10(7):833-40. PubMed ID: 16312179
[TBL] [Abstract][Full Text] [Related]
15. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
Melder DC; Pike GM; VanBrocklin MW; Federspiel MJ
J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
[TBL] [Abstract][Full Text] [Related]
16. Two different molecular defects in the Tva receptor gene explain the resistance of two tvar lines of chickens to infection by subgroup A avian sarcoma and leukosis viruses.
Elleder D; Melder DC; Trejbalova K; Svoboda J; Federspiel MJ
J Virol; 2004 Dec; 78(24):13489-500. PubMed ID: 15564460
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the membrane proximal heptad repeat of the newcastle disease virus fusion protein.
McGinnes LW; Sergel T; Chen H; Hamo L; Schwertz S; Li D; Morrison TG
Virology; 2001 Oct; 289(2):343-52. PubMed ID: 11689056
[TBL] [Abstract][Full Text] [Related]
18. A charged second-site mutation in the fusion peptide rescues replication of a mutant avian sarcoma and leukosis virus lacking critical cysteine residues flanking the internal fusion domain.
Melder DC; Yin X; Delos SE; Federspiel MJ
J Virol; 2009 Sep; 83(17):8575-86. PubMed ID: 19515762
[TBL] [Abstract][Full Text] [Related]
19. The antibodies directed against N-terminal heptad-repeat peptide of hRSV fusion protein and its analog-5-Helix inhibit virus infection in vitro.
Ni L; Zhao L; Gao GF; Qian Y; Tien P
Biochem Biophys Res Commun; 2005 Jun; 331(4):1358-64. PubMed ID: 15883025
[TBL] [Abstract][Full Text] [Related]
20. Six-helix bundle assembly and characterization of heptad repeat regions from the F protein of Newcastle disease virus.
Yu M; Wang E; Liu Y; Cao D; Jin N; Zhang CW; Bartlam M; Rao Z; Tien P; Gao GF
J Gen Virol; 2002 Mar; 83(Pt 3):623-629. PubMed ID: 11842257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
